Howard (Jack)L.WestMD

Oncology • Seattle, WA

Thoracic Cancer

Physician

Join to view full profile

Dr. West is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. West's full profile

Already have an account?

Office
3213 W. Wheeler St.
#405
Seattle, WA 98199
Phone+1 206-898-4515

Summary

Howard (Jack) West, MD, is a thoracic oncologist with over two decades of clinical experience. He led the medical therapeutics component of the thoracic oncology program at the Swedish Cancer Institute in Seattle, WA from 2003-2016. At that time, he moved to City of Hope Comprehensive Cancer Center in the Los Angeles area, where he was Vice President of AccessHope, a novel service providing remote expert cancer consultation services to patients around the US, in addition to serving as a thoracic oncology subspecialist in the clinic and doing telemedicine visits at City of Hope.

In the fall of 2023, Dr. West joined Summit Therapeutics as Vice President of Clinical Development, focused on research and strategy around ivonescimab, a novel bispecific antibody targeting PD-1 and VEGF in lung and other cancer types.

Education & Training

University of WashingtonFellowship, Hematology and Medical Oncology, 1998 - 2002
Brigham and Women's HospitalResidency, Internal Medicine, 1997 - 1998
Brigham and Women's HospitalInternship, Internal Medicine, 1996 - 1997
Harvard Medical SchoolClass of 1996
University of CambridgeM Phil, Experimental Biology, 1990 - 1991

Certifications & Licensure

CA State Medical License 2012 - 2026
NV State Medical License 2022 - 2025
TX State Medical License 2012 - 2025
AK State Medical License 2022 - 2024
ID State Medical License 2022 - 2024
WA State Medical License 1998 - 2024
WY State Medical License 2022 - 2024
ME State Medical License 2020 - 2022
HI State Medical License 2012 - 2016
MA State Medical License 1998 - 2015
NY State Medical License 2012 - 2015
AZ State Medical License 2012 - 2014
FL State Medical License 2012 - 2014
IL State Medical License 2012 - 2014
PA State Medical License 2012 - 2014
VA State Medical License 2012 - 2014
American Board of Internal Medicine Medical Oncology
Join now to see all

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Super Doctor SuperDoctors.com

Clinical Trials

Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2001 Dec 01
Completed
Phase 2
Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer Start of enrollment: 2003 May 01
Unknown status
Phase 1
Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer Start of enrollment: 2003 Jun 01
Completed
Phase 1, Phase 2
Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer Start of enrollment: 2005 Feb 01
Terminated
Phase 2
Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma Start of enrollment: 2007 Jan 01
Completed
Phase 2
S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma Start of enrollment: 2007 Jul 01
Completed
Phase 2
S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer Start of enrollment: 2007 Jul 01
Completed
Phase 2
Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma Start of enrollment: 2007 Mar 01
Completed
Phase 2
LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib Start of enrollment: 2013 Jun 28
COMPLETED
PHASE3
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer Start of enrollment: 2014 Oct 03
ACTIVE_NOT_RECRUITING
PHASE3
Join now to see all

Publications & Presentations

PubMed

Brief Report on Global Clinician Practices in the First-Line Management of Metastatic Non-Small Cell Lung Cancer.
Arthi Sridhar, Howard Jack West, Eric K Singhi
Clinical Lung Cancer. 2024-11-01
2 citations
Examining crossover and postprotocol therapies in first-line immunotherapy trials in non-small cell lung cancer.
Aakash Desai, Caleb J Smith, Joshua C Pritchett, Konstantinos Leventakos, Howard Jack West
Cancer. 2024-08-15
4 citations
Cancer Care in the Era of Artificial Intelligence.
Matthew Kurian, Jacob J Adashek, Howard Jack West
JAMA Oncology. 2024-05-01

External Links

Global Resource for Advancing Cancer Researchhttp://cancerGRACE.org